Elekta has announced its intention to acquire RTA, a leading distributor from Poland specializing in radiation therapy technologies.
Elekta states that the acquisition will significantly strengthen Elekta’s position in the Polish cancer care market.
“The acquisition of RTA would optimally position Elekta to capture the opportunities for the growth of radiation therapy in Poland. Developing the multi-year relationship we have with RTA into the establishment of an Elekta office, is an important step on our path to higher growth,” says Niklas Savander, President and CEO of Elekta.
The acquisition of RTA is expected to add approximately 0.3 percent to Elekta’s revenues on an annual basis. The transaction is expected to be EPS accretive on an annual basis. Once the agreement has been signed and approved, a three-year earn out component between seller and Elekta is expected.
Closing of the deal will take place in January 2015. RTA will then change its name to Elekta and will be a wholly-owned subsidiary.